Basic Information
HIBERIX VACCINE 10 mcg/0.5 ml
INJECTION, POWDER, FOR SOLUTION
Regulatory Information
SIN09859P
July 2, 1998
Prescription Only
Therapeutic
INTRAMUSCULAR
August 10, 2023
June 3, 2025
XJ07AG01
Company Information
GLAXOSMITHKLINE PTE LTD
GLAXOSMITHKLINE PTE LTD
Active Ingredients
PURIFIED CAPSULAR POLYSACCHARIDE OF HIB
Strength: 10mcg/0.5ml
Detailed Information
Contraindications
**Contraindications** _**Hiberix**_ should not be administered to subjects with known hypersensitivity to any component of the vaccine, or to subjects having shown signs of hypersensitivity after previous administration of Hib vaccines.
Indication Information
**Indications** _**Hiberix**_ is indicated for active immunisation of all infants from the age of 6 weeks against disease caused by Hib. _**Hiberix**_ does not protect against disease due to other types of _H. influenzae_ nor against meningitis caused by other organisms.